Zimmer Biomet's Answer to Value-Based Care (MDDI)
The orthopedic giant is packaging services and technologies into an offering aimed at helping hospitals and providers adjust to and thrive under the value-based reimbursement model.
Zimmer Biomet Holdings is using a new approach to maneuver the rapidly shifting reimbursement landscape. On Tuesday, the orthopedics heavyweight announced its new Signature Solutions offering of clinical services and technologies, intended to help clients tackle the new business models expected in a value-based care environment.
Signature Solutions is an offering that company executives seemed to hint at earlier this year when discussing the impact of bundled payment models with industry analysts.
In recent years, payment models focused on the care continuum have become mainstream in the medtech industry. Announced last year, the Comprehensive Care for Joint Replacement (CJR) model has led clinicians, hospitals, and orthopedic companies to pay closer attention to patient rehabilitation and post-acute care. The Medicare Access and CHIP Reauthorization Act of 2015 (MACRA) is transforming payment models further. Other countries are in on the transition too...
